Adial Pharmaceuticals (ADIL) executive compensation, 2026 proxy

Cary Claiborne, Chief Executive Officer and Member of the Board of Directors, was paid $890,653 in 2025, down 26% from $1.2M the year before.

Filed
August 24, 2026
Annual meeting
September 17, 2026
Pay year
2025
Named executives
3
CEO total pay
$890,653-26% vs prior year
CEO bonus
$244,625Accrued, unpaid and discretionary
CEO option awards
$80,5382025 grant-date fair value
CFO total compensation
$458,8552025 Summary Compensation Table
COO total compensation
$469,9672025 Summary Compensation Table
CEO bonus target
50%Of base salary
CFO and COO bonus target
30%Of base salary

How Claiborne was paid

$890,653 in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary55%Bonus27%Option awards9%All other compensation9%

Named executive officers

ExecutiveTotal
Cary ClaiborneChief Executive Officer and Member of the Board of Directors$890,653
Vinay ShahChief Financial Officer$458,855
Tony GoodmanChief Operating Officer$469,967

What changed and why

  • $891K2025 CEO total compensation was $890,653, compared with $1,201,339 in 2024.
  • 50%50% of base salary is Cary Claiborne’s bonus target under his amended employment agreement.
  • $245K$244,625 of 2025 CEO bonus expense was accrued but remained unpaid and discretionary.
  • $80,5385,520 options granted to Cary Claiborne had a $80,538 grant-date fair value.
  • 30%30% of base salary is the discretionary bonus opportunity for Vinay Shah and Tony Goodman.
  • $300KTony Goodman’s 2025 salary was $300,000 after becoming a Company employee on April 1, 2025.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.